Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06683833

Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth

Compare the clinical performance and patient satisfaction of Egyptian MTA, Biodentine versus Calcium Hydroxide as indirect pulp capping materials in permanent teeth

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Deep Caries Biodentine Calcium Hydroxide Indirect Pulp Capping Mineral Trioxide Aggregate (MTA) Patient Reported Outcome Measures

Age range

22 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

El Monira General Hospital

Cairo, Egypt

Location status: Recruiting

Location contact

El Monira General Hospital

CONTACT

0020223947206

About this study

Vital pulp treatments (VPTs) represent a group of minimally invasive treatments intended to preserve the health of all or part of the dental pulp. These treatments include a spectrum of modalities including indirect pulp capping as first option, direct pulp capping and pulpotomy (partial or complete).

Indirect pulp capping (IPC) has been proposed as a conservative pulp therapy for several decades. It is a technique for deep caries management without any features of pulp degeneration.This stimulates tertiary dentin formation, avoiding pulp exposure and maintaining pulp vitality. Cases of indirect pulp capping in deep cavities are those where the residual dentin thickness is equal or less than 0.5 mm, the number and size of the "open" dentinal tubules are such that communication with the pulp parenchyma is comparable to that of a true exposure.

Ideal pulp capping material should maintain pulpal vitality and stimulate reparative dentin formation. These materials should possess certain properties such as biocompatibility, bioactivity, radiopacity, insolubility, dimensional stability, and adequate adhesive ability to both the dentin and to the restorative materials. It should also release remineralizing ions, provide bacterial seal, prevent secondary caries, should have bactericidal or bacteriostatic activity against the causative pathogens, and promote the formation of mineralized tissue

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged 22: 45 years old.
  • Males or females.
  • Patients with vital teeth with deep carious lesions.
  • Patients in good general health.
  • Good oral hygiene.
  • Co-operative patients who show interest to participate in the study.

Exclusion criteria

  • Patients with systemic diseases.
  • Patients with known allergic or adverse reaction to the tested materials.
  • Patients with bad oral hygiene.
  • Patient who frequently use analgesic or any drugs that could mask the pain.

Treatment and study plan

Egyptian MTA

Drug
  • Complete caries removal from the cavity.
  • The liquid of Egyptian MTA (Toothmate) will be mixed with powder according to the manufacturers' instructions.
  • The capping materials will be placed with the passive application on the deepest part of the cavity. Only light pressure will be applied on the MTA mixture using a wet cotton pellet to ensure adaptation of the material onto the dentin.
  • A light-cured glass ionomer cement base will be applied in the cavity .
  • Selective enamel etching will be applied on enamel only.
  • The one-bottle universal adhesive system bond will be applied on enamel and dentine.
  • A Nano hybrid composite resin material will then be incrementally inserted into the cavities.

Biodentine

Drug
  • Complete caries removal from the cavity.
  • Gently tapping a capsule of Biodentine (Septodont) on a hard surface to loosen the powder, then opening the capsule, Detaching a single-dose container of liquid and gently tapping on the sealed cap to force all the liquid down the container, Twisting cap to open, Then Pouring 5 drops from the single-dose container into the capsule, Then Closing the capsule and Placing it on a mixing device for 30 seconds, Then Collecting Biodentine with the instrument supplied in the box.
  • The capping materials will be placed with the passive application on the deepest part of the cavity.
  • A light-cured glass ionomer cement base will be applied in the cavity .
  • Selective enamel etching will be applied on enamel only.
  • The one-bottle universal adhesive system bond will be applied on enamel and dentine.
  • A Nano hybrid composite resin material will then be incrementally inserted into the cavities.

Calcium Hydroxide (Ca(OH)2)

Drug
  • Complete caries removal from the cavity.
  • According to the manufacturers' instructions, Dispensing equal volumes of base and catalyst pastes on the parchment paper pad provided. Using a Dycal (Dentsply) Liner applicator, stirring immediately to mix thoroughly until a uniform color is achieved, complete mixing occurs within 10 seconds, using the ball-pointed Dycal Liner applicator or similar instrument, the mix will be placed directly on the cavity.
  • The capping materials will be placed with the passive application on the deepest part of the cavity.
  • A light-cured glass ionomer cement base will be applied in the cavity .
  • Selective enamel etching will be applied on enamel only.
  • The one-bottle universal adhesive system bond will be applied on enamel and dentine.
  • A Nano hybrid composite resin material will then be incrementally inserted into the cavities.

Primary outcomes

  1. Clinical assessment of treatment success

    Time frame: T( Time) T0( base line)= one week after , T2= 3 months , T3= 6 months

    Pulp response to different stimuli by thermal and electrical pulp tests. When tooth normally responds to thermal and electrical pulp tests = success When tooth doesn't respond to thermal and electrical pulp tests = failure

Secondary outcomes

  1. Clinical assessment of pain

    Time frame: T( time) T0( baseline )= 1 week after, T1= 3 months, T2= 6 months

    Patient reported outcome measures by visual analogue scale visual analogue scale is used to describe the pain by patients themselves in scores as ( 0: no pain ) & (7-10 : Severe pain)

  2. Patient satisfaction with the treatment

    Time frame: T( time) T0= 1 week after, T1= 3 months , T2= 6 months

    Patient reported outcome measure by 4- point likert scale 4- point likert scale used to describe patient satisfaction with the treatment as " (a) yes, very satisfied" & " (d) not all satisfied"

Study contacts

Contact information is provided by the study sponsor or research team.

Alaa T Elsorogy, Master's candidate

CONTACT

[email protected]

0020201010009938

Rawda H AbdElAziz

CONTACT

[email protected]

0020201001097200

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Comparative Analysis of Egyptian MTA, Biodentine, and Calcium Hydroxide as Indirect Pulp Capping Materials in Permanent Teeth. (A 6m Randomized Clinical Trial)

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Nov 12, 2024
Registry last updated
Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.